Skip to content
Back to outputs

Active ulcerative colitis is associated with altered fatty acid precursor availability for the eicosanoid synthetic pathway

Research output: Contribution to journalArticle

Standard

Active ulcerative colitis is associated with altered fatty acid precursor availability for the eicosanoid synthetic pathway. / Pearl, D. S.; Gullick, D.; Bruemmer, J.; Brown, James; Shute, J. K.; Mills, G.; Trebble, T. M.

In: Gut, Vol. 60, No. Suppl 1, 01.04.2011, p. A213-A214.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Pearl, D. S. ; Gullick, D. ; Bruemmer, J. ; Brown, James ; Shute, J. K. ; Mills, G. ; Trebble, T. M. / Active ulcerative colitis is associated with altered fatty acid precursor availability for the eicosanoid synthetic pathway. In: Gut. 2011 ; Vol. 60, No. Suppl 1. pp. A213-A214.

Bibtex

@article{c90549615e694a5db38c7621d3762213,
title = "Active ulcerative colitis is associated with altered fatty acid precursor availability for the eicosanoid synthetic pathway",
abstract = "Introduction The polyunsaturated fatty acids (PUFA) arachidonic acid (AA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA) are generated from dietary essential fatty acids linoleic acid (LA) and α-linolenic acid (αLNA) and direct dietary intake. AA and EPA are substrates for eicosanoid inflammatory mediators that may have critical roles in immunomodulation in Ulcerative Colitis (UC). Dietary supplementation studies alter the availability of specific PUFA (eg, EPA), but clinical studies have been disappointing leading to the hypothesis that the PUFA biosynthetic pathway in inflamed tissue may be altered. This study evaluated PUFA bioavailability in inflamed and uninflamed mucosa from UC patients and compared to matched controls.Methods Ethical approval was obtained. Patients were prospectively recruited from outpatients' clinics. Mucosal biopsies at flexible sigmoidoscopy (FS) were taken from active UC patients within inflamed (active) and endoscopically normal proximal mucosa (internal control). Age-sex matched patients undergoing FS for IBS or similar presentations were compared (external controls). Mucosal samples were saponified, deuterated internal standards added, lipids hydrolysed and fatty acids derivatised prior to liquid-liquid extraction into heptane. PUFA were quantified by gas chromatography mass spectrometry. Data was expressed as percentage mass abundance and compared using Wilcoxon signed rank pair analysis for non-parametric data.Results 69 active UC patients (54 paired normal/inflamed mucosa) and 69 controls were compared. No biologically significant differences were noted between endoscopically normal mucosa from UC patients and external controls other than DPA (p<0.0025). Inflamed mucosa compared to both control groups demonstrated highly significant reductions in the essential fatty acids LA and αLNA (p<0.0001) and increased AA, DPA and DHA (p<0.0001); EPA was reduced (p<0.005). The ratio of AA/EPA was increased in inflamed mucosa (p<0.0001)",
author = "Pearl, {D. S.} and D. Gullick and J. Bruemmer and James Brown and Shute, {J. K.} and G. Mills and Trebble, {T. M.}",
year = "2011",
month = apr,
day = "1",
doi = "10.1136/gut.2011.239301.449",
language = "English",
volume = "60",
pages = "A213--A214",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group Ltd and British Society of Gastroenterology",
number = "Suppl 1",

}

RIS

TY - JOUR

T1 - Active ulcerative colitis is associated with altered fatty acid precursor availability for the eicosanoid synthetic pathway

AU - Pearl, D. S.

AU - Gullick, D.

AU - Bruemmer, J.

AU - Brown, James

AU - Shute, J. K.

AU - Mills, G.

AU - Trebble, T. M.

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Introduction The polyunsaturated fatty acids (PUFA) arachidonic acid (AA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA) are generated from dietary essential fatty acids linoleic acid (LA) and α-linolenic acid (αLNA) and direct dietary intake. AA and EPA are substrates for eicosanoid inflammatory mediators that may have critical roles in immunomodulation in Ulcerative Colitis (UC). Dietary supplementation studies alter the availability of specific PUFA (eg, EPA), but clinical studies have been disappointing leading to the hypothesis that the PUFA biosynthetic pathway in inflamed tissue may be altered. This study evaluated PUFA bioavailability in inflamed and uninflamed mucosa from UC patients and compared to matched controls.Methods Ethical approval was obtained. Patients were prospectively recruited from outpatients' clinics. Mucosal biopsies at flexible sigmoidoscopy (FS) were taken from active UC patients within inflamed (active) and endoscopically normal proximal mucosa (internal control). Age-sex matched patients undergoing FS for IBS or similar presentations were compared (external controls). Mucosal samples were saponified, deuterated internal standards added, lipids hydrolysed and fatty acids derivatised prior to liquid-liquid extraction into heptane. PUFA were quantified by gas chromatography mass spectrometry. Data was expressed as percentage mass abundance and compared using Wilcoxon signed rank pair analysis for non-parametric data.Results 69 active UC patients (54 paired normal/inflamed mucosa) and 69 controls were compared. No biologically significant differences were noted between endoscopically normal mucosa from UC patients and external controls other than DPA (p<0.0025). Inflamed mucosa compared to both control groups demonstrated highly significant reductions in the essential fatty acids LA and αLNA (p<0.0001) and increased AA, DPA and DHA (p<0.0001); EPA was reduced (p<0.005). The ratio of AA/EPA was increased in inflamed mucosa (p<0.0001)

AB - Introduction The polyunsaturated fatty acids (PUFA) arachidonic acid (AA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA) are generated from dietary essential fatty acids linoleic acid (LA) and α-linolenic acid (αLNA) and direct dietary intake. AA and EPA are substrates for eicosanoid inflammatory mediators that may have critical roles in immunomodulation in Ulcerative Colitis (UC). Dietary supplementation studies alter the availability of specific PUFA (eg, EPA), but clinical studies have been disappointing leading to the hypothesis that the PUFA biosynthetic pathway in inflamed tissue may be altered. This study evaluated PUFA bioavailability in inflamed and uninflamed mucosa from UC patients and compared to matched controls.Methods Ethical approval was obtained. Patients were prospectively recruited from outpatients' clinics. Mucosal biopsies at flexible sigmoidoscopy (FS) were taken from active UC patients within inflamed (active) and endoscopically normal proximal mucosa (internal control). Age-sex matched patients undergoing FS for IBS or similar presentations were compared (external controls). Mucosal samples were saponified, deuterated internal standards added, lipids hydrolysed and fatty acids derivatised prior to liquid-liquid extraction into heptane. PUFA were quantified by gas chromatography mass spectrometry. Data was expressed as percentage mass abundance and compared using Wilcoxon signed rank pair analysis for non-parametric data.Results 69 active UC patients (54 paired normal/inflamed mucosa) and 69 controls were compared. No biologically significant differences were noted between endoscopically normal mucosa from UC patients and external controls other than DPA (p<0.0025). Inflamed mucosa compared to both control groups demonstrated highly significant reductions in the essential fatty acids LA and αLNA (p<0.0001) and increased AA, DPA and DHA (p<0.0001); EPA was reduced (p<0.005). The ratio of AA/EPA was increased in inflamed mucosa (p<0.0001)

U2 - 10.1136/gut.2011.239301.449

DO - 10.1136/gut.2011.239301.449

M3 - Article

VL - 60

SP - A213-A214

JO - Gut

JF - Gut

SN - 0017-5749

IS - Suppl 1

ER -

ID: 1918799